Intent Biologics
Phase 2INTENT Biologics develops first-in-class regenerative exosome therapies for chronic wounds and autoimmune skin diseases.
Founded
2021
Employees
201-500
Focus
Biologics
About
INTENT Biologics develops first-in-class regenerative exosome therapies for chronic wounds and autoimmune skin diseases.
Company Info
TypePrivate
Founded2021
Employees201-500
LocationCambridge, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile